Gallbladder cancer
Conditions
Interventions
Group A (number of lymph node dissection<6) and Group B (number of lymph node dissection = 6):None
Sponsors
Sir Run-Run Shaw Hospital, Zhejiang University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age= 18 years old. (2) Patients diagnosed with gallbladder cancer in the Department of General Surgery, Sir Run Shaw Hospital, Zhejiang University School of Medicine from October 2022 to September 2023. (3) Postoperative pathological diagnosis of gallbladder cancer, with negative margins and positive lymph nodes. (4) Postoperative treatment with capecitabine combined with putelimab. (5) No other malignant tumors. (6) Postoperative follow-up time= 3 months.
Exclusion criteria
Exclusion criteria: (1) Those with incomplete clinical data. (2) Patients who have received prior systemic therapy with PD1 antibody, PDL1 antibody or CTLA4 antibody, TKI inhibitor, and chemotherapy. (3) Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, etc. (4) Patients with positive margins. (5) Patients undergoing palliative surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-free survival;Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events;Severe adverse events;Quality of life; | — |
Countries
China
Contacts
Public ContactChen Mingyu
Sir Run-Run Shaw Hospital, Zhejiang University
Outcome results
None listed